SCHEMBL20879006

SCHEMBL20879006

CCNC(=O)c1nnc(-c2cc(C(C)C)c(O)cc2O)n1-c1ccc(C(=O)N2CCCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 17/20 0.49
ERBB2 P04626 2/20 0.48
HSP90AA1 P07900 13/20 0.44
PDK1 Q15118 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28130292 0.99 HSP90AB1 (0.49) HSP90AB1ERBB2HSP90AA1PDK1HDAC3
SCHEMBL16569528 0.93 ERBB2 (0.47) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL501462 0.93 HSP90AB1 (0.53) HSP90AB1ERBB2HSP90AA1
SCHEMBL15525677 0.92 ERBB2 (0.47) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL15525642 0.92 ERBB2 (0.47) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL17293935 0.91 ERBB2 (0.46) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL17293934 0.91 ERBB2 (0.46) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL17293936 0.91 ERBB2 (0.46) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL15525645 0.90 ERBB2 (0.47) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4
SCHEMBL15604174 0.90 HSP90AB1 (0.46) HSP90AB1ERBB2HSP90AA1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3738594-A1 TARGETED THERAPEUTICS HAVING AN HSP90 LIGAND AS BINDING MOIETY Madrigal Pharmaceuticals, Inc. (US) 2020-11-18 EP disclosed
EP-3035938-B1 TARGETED THERAPEUTICS MADRIGAL PHARMACEUTICALS INC (US) 2020-08-19 EP disclosed
EP-3466416-A2 A BINDING MOIETY-DRUG CONJUGATE COMPRISING A HSP90 BINDING MOIETY AND A CYTOTOXIC EFFECTOR MOIETY Madrigal Pharmaceuticals, Inc. (US) 2019-04-10 EP disclosed